License, Acquisitions and Other Agreements - ALS Biopharma Agreement (Details) |
1 Months Ended | 3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|---|
|
Aug. 31, 2015
claim
prodrug
|
Sep. 30, 2024
USD ($)
|
Sep. 30, 2023
USD ($)
|
Sep. 30, 2024
USD ($)
|
Sep. 30, 2023
USD ($)
|
|
| License and other agreements | |||||
| Milestone payment to be paid upon regulatory achievement | $ 641,975,000 | $ 641,975,000 | |||
| Research and development | 157,607,000 | $ 95,517,000 | 628,398,000 | $ 238,468,000 | |
| ALS Biopharma Agreement | Collaborative arrangement | |||||
| License and other agreements | |||||
| Number of prodrugs of glutamate modulating agents | prodrug | 300 | ||||
| Milestone payment to be paid upon regulatory achievement | 4,000,000 | 4,000,000 | |||
| Number of claims | claim | 1 | ||||
| Research and development | $ 0 | $ 0 | $ 0 | $ 0 | |